24.05.2013 • NewsAir LiquideChinaIndustrial gases

Air Liquide Awarded Coal Gasification Contract in China

Air Liquide has just signed a long-term contract with Fujian Shenyuan New Materials (Fujian Shenyuan) to supply industrial gases for its caprolactam production project located in Lianjiang Kemen Economic & Development Zone, Fujian Province, South-East of China.

Under the terms of the contract, Air Liquide will invest in an industrial gases complex of eight units including an Air Separation Unit of 2,000 tons of oxygen per day, a Gasification unit, a Purification unit of synthesis gas (RectisolTM) and an ammonia plant to supply hydrogen, nitrogen and ammonia.

These plants, to be commissioned beginning of 2016, will produce 75,000 Nm3/h of hydrogen and 250,000 tons per year of ammonia.

Fujian Shenyuan is a private company. The Group who owns Fujian Shenyuan also owns two other downstream companies, to which Fujian Shenyuan will supply 100% of its caprolactam production. These two companies together have a 12% market share of the nylon textile filament market in China.

 

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.